Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
After finishing at $95.52 in the prior trading day, Boston Scientific Corp (NYSE: BSX) closed at $96.42, up 0.94%. In other words, the price has increased by $0.94 from its previous closing price. On the day, 8.79 million shares were traded. BSX stock price reached its highest trading level at $98.565 during the session, while it also had its lowest trading level at $96.01.
Ratios:
Our goal is to gain a better understanding of BSX by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 271.04 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 53.80. For the most recent quarter (mrq), Quick Ratio is recorded 0.64 and its Current Ratio is at 1.08. In the meantime, Its Debt-to-Equity ratio is 0.52 whereas as Long-Term Debt/Eq ratio is at 0.43.
On May 30, 2024, Goldman started tracking the stock assigning a Buy rating and target price of $90.Goldman initiated its Buy rating on May 30, 2024, with a $90 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 03 ’25 when Woodworth Emily sold 7,149 shares for $104.97 per share. The transaction valued at 750,465 led to the insider holds 914 shares of the business.
Woodworth Emily sold 482 shares of BSX for $50,432 on Mar 04 ’25. The SVP, Global Controller and CAO now owns 432 shares after completing the transaction at $104.63 per share. On Feb 28 ’25, another insider, Woodworth Emily, who serves as the SVP, Global Controller and CAO of the company, sold 9,887 shares for $101.13 each. As a result, the insider received 999,872 and left with 1,632 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BSX now has a Market Capitalization of 142294695936 and an Enterprise Value of 152013324288. As of this moment, Boston’s Price-to-Earnings (P/E) ratio for their current fiscal year is 77.29, and their Forward P/E ratio for the next fiscal year is 29.55. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 5.70. For the stock, the TTM Price-to-Sale (P/S) ratio is 8.50 while its Price-to-Book (P/B) ratio in mrq is 6.53. Its current Enterprise Value per Revenue stands at 9.077 whereas that against EBITDA is 35.592.
Stock Price History:
The Beta on a monthly basis for BSX is 0.76, which has changed by 0.4421178 over the last 52 weeks, in comparison to a change of 0.087141395 over the same period for the S&P500. Over the past 52 weeks, BSX has reached a high of $107.17, while it has fallen to a 52-week low of $65.52. The 50-Day Moving Average of the stock is -3.75%, while the 200-Day Moving Average is calculated to be 11.29%.
Shares Statistics:
The stock has traded on average 6.64M shares per day over the past 3-months and 9970380 shares per day over the last 10 days, according to various share statistics. A total of 1.47B shares are outstanding, with a floating share count of 1.47B. Insiders hold about 0.47% of the company’s shares, while institutions hold 92.02% stake in the company. Shares short for BSX as of 1740700800 were 12873554 with a Short Ratio of 1.94, compared to 1738281600 on 10449826. Therefore, it implies a Short% of Shares Outstanding of 12873554 and a Short% of Float of 0.8699999999999999.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
